What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?

Gavin I W Galasko; Sophie C Barnes; Paul Collinson; Avijit Lahiri; Roxy Senior

What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?

Authors

Galasko, Gavin I W
Barnes, Sophie C
Collinson, Paul
Lahiri, Avijit
Senior, Roxy

Type

Published Article

Journal

European Heart Journal - Cardiovascular Imaging

Publisher

Oxford University Press

Publication Date

January 2006

Volume

27

Issue

2

Pages

193–200

Identifiers

PMID: 16267076

Source

Medline

License

Unknown

Abstract

Thus several different modalities allow cost-effective community-based screening for LVSD, especially in high-risk subjects. Such programmes would be cost-effective and miss few cases of LVSD in the community.

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. This record was last updated on 06/08/2017 and may not reflect the most current and accurate biomedical/scientific data available from NLM. The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/16267076

Report this publication

Statistics

Seen <100 times